Addressing Counterfeit Medicines and Community Risk: Insights from South African Spaza Shops
Main Article Content
Abstract
Background: Governance and regulatory enforcement in South Africa reveal complex interactions among formal legal frameworks, operational capacity, and informal market practices. While deliberative processes, such as public consultations on the draft Traditional Courts Regulations, demonstrate transparency and inclusivity, interventions in the healthcare sector are often reactive, triggered by crises such as food contamination fatalities and the sale of illegal medicines. This contrast underscores disparities in institutional capacity and sectoral prioritisation.
Objectives: This paper investigated regulatory gaps and enforcement challenges in informal medicine markets, with a focus on spaza shops. The focus was on structural, operational, and social factors influencing the circulation of counterfeit, expired, and improperly stored medicines, and explores how governance, public service delivery, and community dynamics interact to affect public health outcomes.
Methods: A qualitative case-study approach guided this research, focusing on the analysis of secondary data sources and qualitative literature. Purposive selection of documents and reports included government communications, regulatory guidelines, parliamentary hearing transcripts, media coverage, and peer-reviewed studies, ensuring that the sources provided rich insights into governance, regulatory enforcement, and informal pharmaceutical practices.
Findings: Systemic gaps exist between regulatory intent and operational reality. Although legal frameworks restrict the dispensing of scheduled medicines to licensed pharmacies and authorised health professionals, widespread non-compliance persists in township spaza shops.
Conclusion: Effective mitigation of counterfeit and illegally sold medicines requires an integrated, multi-dimensional approach that strengthens regulatory oversight, secures supply chains, mobilises community engagement, and leverages technological monitoring. The proposed Integrated Regulatory-Community Framework for Counterfeit Medicines in Spaza Shops (IRCF-CMSS) aligns formal legislation with practical enforcement and social realities, promoting sustained compliance, enhanced public safety, and institutional trust.
Downloads
Article Details
Copyright (c) 2026 Michael Mncedisi Willie, Athandile Hadebe

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Authors retain copyright and acknowledge that the Journal of Multidisciplinary Applied Natural Science is the first publisher, licensed under a Creative Commons Attribution License.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges and earlier and greater citation of published work.
References
A’aqoulah A, El-Metwally AA, Al Khateeb B, Alammari D, Alshahrani A, Aldubikhi A, Alsulami A, Fatani F, Innab N. Challenges and opportunities of complexity theory in health care systems. J Taibah Univ Med Sci. 2025;20(4):429–434. https://doi.org/10.1016/j.jtumed.2025.06.006
Abdunasir E, Sosengo T, Amare F. Assessment of awareness and attitude towards counterfeit medicines among pharmacy professionals working in community drug retail outlets in Harar town, Ethiopia. OJPSR. 2021;11(1). https://doi.org/10.36811/ojpsr.2020.110010
Adigwe OP, Onavbavba G, Wilson DO. Challenges associated with addressing counterfeit medicines in Nigeria: An exploration of pharmacists’ knowledge, practices, and perceptions. Integr Pharm Res Pract. 2022;11:177–186. https://doi.org/10.2147/IPRP.S387354
Akyildirim E, Corbet S, Nicolau JL, Oxley L. Understanding reputational disaster during economic crises: Evaluating aviation sector response differentials. Tour Manag. 2025;106:105028. https://doi.org/10.1016/j.tourman.2024.105028
Callanan A. How to check and identify fake medicines. Pfizer Global Security. 2021. https://www.pfizer.com
Caxton Local Media. Local shop owner caught with unlicensed products [Internet]. Soweto Urban: The Citizen; 2026 Feb 28 [cited 2026 Feb 28]. Available from: https://www.citizen.co.za/news/local-news/
Chabalenge B, Sahota T, Ermolina I, Tanna S. Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges and strategies to increase access to quality medicines. Front Pharmacol. 2025;16:1708784. https://doi:10.3389/fphar.2025.1708784
Department of Justice and Constitutional Development. Public has until 13 February to comment on draft Traditional Courts Regulations. 2025 Dec 26.
Eid J, Hansen AL, Andreassen N, Espevik R, Brattebø G, Johnsen BH. Developing local crisis leadership – A research and training agenda. Front Psychol. 2023;14:1041387. https://doi.org/10.3389/fpsyg.2023.1041387
Feeney AJ, Goad JA, Flaherty GT. Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature. Travel Med Infect Dis. 2024;61:102758. https://doi.org/10.1016/j.tmaid.2024.102758
Gauteng Department of Health. Gauteng Health warns shops against the sale of scheduled medication without a licence. 2024 Nov 7. www.gov.za
Hornberger J, Hodges S, Chitukutuku E. Fake-talk and the spaza shop: A fake food furore and the spectre of public health emergencies in South Africa. Matatu J Afr Media Stud. 2023;10(3):71–136. https://doi.org/10.17157/mat.10.3.7136
Katerere DR. Fake medicines are a dangerous threat in Africa: 3 ways to spot them. The Conversation. 2025. https://theconversation.com
Koko M. GP Health looks to SAHPRA to establish task team tackling illegal sale of medicine at spaza shops. 2024 Nov 9. https://www.ewn.co.za
Laird Y, Manner J, Baldwin L, Hunter R, McAteer J, Rodgers S, Williamson C, Jepson R. Stakeholders’ experiences of the public health research process: time to change the system? Health Res Policy Syst. 2020;18:83. https://doi.org/10.1186/s12961-020-00599-5
Moshoeshoe RJ, Enslin GM, Katerere DR. An exploratory assessment of the legislative framework for combating counterfeit medicines in South Africa. J Pharm Policy Pract. 2022;15(1). https://doi.org/10.1186/s40545-021-00387-8
Mourad N, Haddad C, Sacre H, Al Tawil S, Zeenny RM, Younes S, et al. Knowledge, practices, and recognition ability of counterfeit medicines among Lebanese community pharmacists during concurrent national crises. Sci Rep. 2026;16:109. https://doi:10.1038/s41598-025-00000-x
Ofori-Parkus S, Park SE. I (don’t) want to consume counterfeit medicines: Exploratory study on the antecedents of consumer attitudes toward counterfeit medicines. BMC Public Health. 2022;22:13529. https://doi.org/10.1186/s12889-022-13529-7
Ofori-Parku SS. Fighting the global counterfeit medicines challenge: A consumer-facing communication strategy in the US is an imperative. J Glob Health. 2022;12:03018. https://doi.org/10.7189/jogh.12.03018
Organisation for Economic Co-operation and Development (OECD). Trade in Counterfeit Pharmaceutical Products. Paris: OECD Publishing; 2020. https://www.oecd.org
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, … Moher D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71
Pal E, Merchant L, Koffi AK, Mehta R, Rusatira JC, Kubiak L. Assessing knowledge, attitudes, and practices and demand-side interventions for combating substandard and falsified medicines: A scoping review. J Pharm Policy Pract. 2025;18(1):2550369. https://doi.org/10.1080/20523211.2025.2550369
Parliamentary Monitoring Group. Medicines and Related Substances Amendment Bill: Public hearings. 2008 Aug 5. https://pmg.org.za/committee-meeting/861/
Pharmaceutical Society of South Africa. Limits on dispensing and sales of prescription and over the counter medicines [PDF]. 2020 Mar 24. https://www.pssa.org.za
Quttainah MA, Pathak A, Soni T. Configurations of corporate governance mechanisms and sustainable development: a review [Internet]. Indian J Corp Gov. 2025 Apr 21;18(1). Available from: https://doi.org/10.1177/09746862251327829
Rigby BP, Dodd-Reynolds CJ, Oliver EJ. The understanding, application and influence of complexity in national physical activity policy-making. Health Res Policy Syst. 2022;20:59. https://doi.org/10.1186/s12961-022-00857-9
Rotea CC, Ploscaru AN, Bocean CG, Vărzaru AA, Mangra MG, Mangra GI. The link between HRM practices and performance in healthcare: the mediating role of the organizational change process [Internet]. Healthcare (Basel). 2023 Apr 26;11(9):1236. Available from: https://doi.org/10.3390/healthcare11091236
Snyder H. Literature review as a research methodology: An overview and guidelines. J Bus Res. 2019;104:333–339. https://doi:10.1016/j.jbusres.2019.07.039
South African Health Products Regulatory Authority (SAHPRA). SA’s health emergency: Efforts to tackle unhealthy medication sales [Television broadcast]. eNCA, DStv Channel 403; 2024 Nov 14.
Swami Gurunand Jnanathapaswi. Thematic analysis & coding: An overview of the qualitative paradigm. In: An introduction to social science research. APH Publishing Corporation; 2021. https://doi.org/10.6084/m9.figshare.17159249
Tate JA, Happ MB. Qualitative secondary analysis: A case exemplar. J Pediatr Health Care. 2017;32(3):308–312. https://doi:10.1016/j.pedhc.2017.09.007
Tshikalange S. Scheduled medication sold illegally at shops: Selling scheduled medication without a licence places lives at risk. TimesLIVE. 2024 Nov 8. https://www.timeslive.co.za/news/south-africa/
Willie MM. A review of the diversity and characteristics of Spaza shops in South Africa. Golden Ratio of Data in Summary. 2025;5(2):44–46. https://doi.org/10.52970/grdis.v5i2.467
World Health Organization (WHO). Substandard and falsified medical products. 2024 Dec 3. https://www.who.int
Michael Mncedisi Willie